Document Detail


Combining traditional systemic and biologic therapies for psoriasis.
MedLine Citation:
PMID:  20430311     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The year 2010 marks 8 years since etanercept obtained approval from the Food and Drug Administration for the treatment of psoriatic arthritis. There are 6 biologic therapies approved by the Food and Drug Administration for the treatment of psoriasis and/or psoriatic arthritis. These biologics are often used in patients who have received, are receiving, or will receive in the future the traditional systemic antipsoriatics. In this article, the currently available data on combining these therapies are reviewed.
Authors:
Michael P Heffernan
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in cutaneous medicine and surgery     Volume:  29     ISSN:  1558-0768     ISO Abbreviation:  Semin Cutan Med Surg     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-04-30     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9617260     Medline TA:  Semin Cutan Med Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  67-9     Citation Subset:  IM    
Affiliation:
Clinical Dermatology, St. Louis, MO 63117, USA. heffernan@centralderm.com <heffernan@centralderm.com>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use*
Biological Products / therapeutic use*
Combined Modality Therapy
Dermatologic Agents / therapeutic use*
Humans
Immunologic Factors / therapeutic use*
Phototherapy*
Psoriasis / therapy*
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Biological Products; 0/Dermatologic Agents; 0/Immunologic Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The future of biological therapies.
Next Document:  Headache.